Loading...
Meloxicam
India Pharmaceutical Trade Intelligence
Who Supplies Meloxicam to India from UNITED STATES
India's meloxicam imports from UNITED STATES total $1.1M across 76 shipments from 13 foreign suppliers. MSN PHARMACEUTICALS INC. leads with $1.1M in import value; the top 5 suppliers together control 99.3% of this origin. Leading Indian buyers include XYLOPIA LABS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for meloxicam — a diversified sourcing base with multiple active suppliers from UNITED STATES.
Top foreign suppliers (UNITED STATES) — Ranked by import value
MSN PHARMACEUTICALS INC. is the leading Meloxicam supplier from UNITED STATES to India, with import value of $1.1M across 12 shipments. The top 5 suppliers — MSN PHARMACEUTICALS INC., AMSTERDAM PHARMA (APTEKA RX INC.), AGRACE PHARMA, PHARMACEUTICAL BUYERS, INC, OCEAN VIEW VETERINARY HOSPITAL. — collectively account for 99.3% of total import value from this origin.
Top foreign suppliers (UNITED STATES)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MSN PHARMACEUTICALS INC. | $1.1M | 12 | 96.9% |
| 2 | AMSTERDAM PHARMA (APTEKA RX INC.) | $12.9K | 3 | 1.1% |
| 3 | AGRACE PHARMA | $5.1K | 2 | 0.4% |
| 4 | PHARMACEUTICAL BUYERS, INC | $4.8K | 1 | 0.4% |
| 5 | OCEAN VIEW VETERINARY HOSPITAL. | $3.8K | 4 | 0.3% |
| 6 | OCEAN VIEW VETERINARY HOSPITAL | $3.6K | 4 | 0.3% |
| 7 | NOVITIUM PHARMA LLC | $1.3K | 33 | 0.1% |
| 8 | PHARMACEUTICAL BUYERS,INC. | $1.3K | 3 | 0.1% |
| 9 | Pharmaceutical Buyers, Inc. | $1.1K | 2 | 0.1% |
| 10 | ASCENT PHARMACEUTICALS INC | $510 | 7 | 0.0% |
| 11 | ZYDUS HEALTHCARE USA LLC | $296 | 1 | 0.0% |
| 12 | BILCARE GCS INC | $245 | 2 | 0.0% |
| 13 | ZYDUS HEALTHCARE (USA) LLC | $133 | 2 | 0.0% |
Showing top 13 of 13 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED STATES)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | XYLOPIA LABS PRIVATE LIMITED | $1.1M | 21 | 98.0% |
| 2 | SLAYBACK PHARMA INDIA LLP | $12.9K | 3 | 1.1% |
| 3 | INTAS PHARMACEUTICALS LTD | $5.1K | 2 | 0.4% |
| 4 | MYLAN LABORATORIES LIMITED | $2.4K | 5 | 0.2% |
| 5 | NOVITIUM LABS PRIVATE LIMITED | $1.3K | 33 | 0.1% |
| 6 | ASPHAR RESEARCH LABS PRIVATE LIMITED | $510 | 7 | 0.0% |
| 7 | CADILA HEALTHCARE LIMITED | $429 | 2 | 0.0% |
| 8 | TENSHI KAIZEN PRIVATE LIMITED | $245 | 2 | 0.0% |
| 9 | ZYDUS LIFESCIENCES LIMITED | $1 | 1 | 0.0% |
Import Statistics
- Import Value
- $1.1M
- Shipments
- 76
- Foreign Suppliers
- 13
- Indian Buyers
- 9
- Avg. Shipment
- $15.1K
Other Meloxicam Import Origins
Related Analysis
Frequently Asked Questions — Meloxicam Imports from UNITED STATES
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Meloxicam suppliers from UNITED STATES to India?
The top Meloxicam suppliers from UNITED STATES to India include MSN PHARMACEUTICALS INC., AMSTERDAM PHARMA (APTEKA RX INC.), AGRACE PHARMA. The leading supplier is MSN PHARMACEUTICALS INC. with import value of $1.1M USD across 12 shipments. India imported Meloxicam worth $1.1M USD from UNITED STATES in total across 76 shipments.
QHow much Meloxicam does India import from UNITED STATES?
India imported Meloxicam worth $1.1M USD from UNITED STATES across 76 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Meloxicam from UNITED STATES?
The main Indian buyers of Meloxicam sourced from UNITED STATES include XYLOPIA LABS PRIVATE LIMITED, SLAYBACK PHARMA INDIA LLP, INTAS PHARMACEUTICALS LTD. The largest buyer is XYLOPIA LABS PRIVATE LIMITED with $1.1M in imports across 21 shipments.
QWhat is the total value of Meloxicam imports from UNITED STATES to India?
The total value of Meloxicam imports from UNITED STATES to India is $1.1M USD, across 76 shipments and 13 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED STATES to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Meloxicam.
- 2.Supplier/Buyer Matching: 13 foreign suppliers from UNITED STATES and 9 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $1.1M aggregated from 76 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
76 Verified Shipments
13 suppliers, 9 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists